Werbung
Werbung

MRK

MRK logo

Merck & Co., Inc.

108.87
USD
Gesponsert
+1.42
+1.33%
06. Jan., 15:59 UTC -5
Geschlossen
exchange

Vor-Markt

108.92

+0.05
+0.05%

MRK Ergebnisberichte

Positives Überraschungsverhältnis

MRK übertreffen die 33 der letzten 39Schätzungen.

85%

Nächster Bericht

Datum des nächsten Berichts
03. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$16.36B
/
$2.07
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-5.31%
/
-22.76%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+4.71%
/
+20.35%

Merck & Co., Inc. earnings per share and revenue

On 30. Okt. 2025, MRK reported earnings of 2.68 USD per share (EPS) for Q3 25, beating the estimate of 2.37 USD, resulting in a 13.06% surprise. Revenue reached 17.28 milliarde, compared to an expected 17.13 milliarde, with a 0.83% difference. The market reacted with a -0.35% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of 2.07 USD, with revenue projected to reach 16.36 milliarde USD, implying an decrease of -22.76% EPS, and decrease of -5.31% in Revenue from the last quarter.
FAQ
For Q3 2025, Merck & Co., Inc. reported EPS of $2.68, beating estimates by 13.06%, and revenue of $17.28B, 0.83% above expectations.
The stock price moved down -0.35%, changed from $86.58 before the earnings release to $86.28 the day after.
The next earning report is scheduled for 03. Feb. 2026.
Based on 18 analysts, Merck & Co., Inc. is expected to report EPS of $2.07 and revenue of $16.36B for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung